AX Stock Analysis: Axos Financial | NYSE
Banks - Regional | NYSE, USA | Market Cap: 5.109m USD | 12M Return: 16.4% | US05465C1009 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 30.4M
EPS Trend: 95.4%
Qual. Beats: 1
Rev. Trend: 92.9%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Axos Financial, Inc. (NYSE: AX) is a U.S.-based financial holding company that provides consumer and business banking products through two operating segments: Banking Business and Securities Business. The Banking segment offers a full suite of deposit products-including checking, savings, money market, and time deposits-alongside a diversified lending portfolio spanning residential, multifamily, and commercial mortgage loans, commercial real estate and asset-based loans, auto and unsecured consumer loans, and specialty lending such as lender finance, capital call facilities, equipment lending and leasing, and marine floor plan financing. The Securities Business provides investment and wealth management services, including clearing, recordkeeping, trade reporting, custody, margin lending, and retail self-directed and digital advisory offerings.
The company distributes its products through digital online and mobile banking platforms, as well as through direct channels and affinity partners. Originally incorporated in 1999 as BofI Holding, Inc., the company rebranded to Axos Financial in September 2018 and is headquartered in Las Vegas, Nevada. As a digitally-oriented regional bank operating under the Financials sector, Axos competes in the U.S. regional banking space, where peers typically focus on geographically concentrated deposit gathering and relationship-based lending.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses weigh on credit costs
- Lender finance and specialty lending portfolio drives loan growth
| Net Income: 490.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.22 > 1.0 |
| NWC/Revenue: -1.06k% < 20% (prev -974.7%; Δ -83.76% < -1%) |
| CFO/TA 0.02 > 3% & CFO 557.6m > Net Income 490.4m |
| Net Debt (-88.8m) to EBITDA (727.3m): -0.12 < 3 |
| Current Ratio: 0.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.7m) vs 12m ago 0.31% < -2% |
| Gross Margin: 62.97% > 18% (prev 61.47%; Δ 1.50% > 0.5%) |
| Asset Turnover: 8.00% > 50% (prev 7.79%; Δ 0.22% > 0%) |
| Interest Coverage Ratio: 0.91 > 6 (EBIT TTM 646.7m / Interest Expense TTM 710.0m) |
| A: -0.77 (Total Current Assets 1.84b - Total Current Liabilities 25.0b) / Total Assets 30.0b |
| B: 0.10 (Retained Earnings 3.11b / Total Assets 30.0b) |
| C: 0.02 (EBIT TTM 646.7m / Avg Total Assets 27.4b) |
| D: 0.12 (Book Value of Equity 3.17b / Total Liabilities 26.8b) |
| Altman-Z'' = -4.46 = D |
| DSRI: 1.13 (Receivables 478.3m/374.3m, Revenue 2.19b/1.93b) |
| GMI: 0.98 (GM 61.47% / 62.97%) |
| AQI: 1.04 (AQ_t 0.93 / AQ_t-1 0.90) |
| SGI: 1.14 (Revenue 2.19b / 1.93b) |
| TATA: -0.00 (NI 490.4m - CFO 557.6m) / TA 30.0b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of October 24, 2026, the stock is trading at USD 91.79 with a total of 258,375 shares traded. Over the past week, the price has changed by +4.14%, over one month by +4.77%, over three months by -3.60% and over the past year by +16.44%.
Current recommended Stop Loss: 88.40 (which is 3.7% or 1.6 ATR below the current price).
Axos Financial has received a consensus analysts rating of 4.57. Therefore, it is recommended to buy AX.
- StrongBuy: 5
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 117.7 | 28.2% |
P/E Trailing = 10.5967
P/E Forward = 9.5511
P/S = 3.704
P/B = 1.5697
P/EG = 0.9498
Revenue TTM = 2.19b USD
EBIT TTM = 646.7m USD
EBITDA TTM = 727.3m USD
Long Term Debt = 979.6m USD (from longTermDebt, last quarter)
Short Term Debt = 94.0m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -88.8m USD (calculated: Debt 1.07b - CCE 1.16b)
Enterprise Value = 5.02b USD (5.11b + Debt 1.07b - CCE 1.16b)
Interest Coverage Ratio = 0.91 (Ebit TTM 646.7m / Interest Expense TTM 710.0m)
EV/FCF = 10.86x (Enterprise Value 5.02b / FCF TTM 462.3m)
FCF Yield = 9.21% (FCF TTM 462.3m / Enterprise Value 5.02b)
FCF Margin = 21.10% (FCF TTM 462.3m / Revenue TTM 2.19b)
Net Margin = 22.39% (Net Income TTM 490.4m / Revenue TTM 2.19b)
Gross Margin = 62.97% ((Revenue TTM 2.19b - Cost of Revenue TTM 811.1m) / Revenue TTM)
Gross Margin QoQ = 65.04% (prev 62.25%)
Tobins Q-Ratio = 0.17 (Enterprise Value 5.02b / Total Assets 30.0b)
Interest Expense / Debt = 66.14% (Interest Expense 710.0m / Debt 1.07b)
Taxrate = 24.17% (156.3m / 646.7m)
NOPAT = 490.4m (EBIT 646.7m * (1 - 24.17%))
Current Ratio = 0.07 (Total Current Assets 1.84b / Total Current Liabilities 25.0b)
Debt / Equity = 0.34 (Debt 1.07b / totalStockholderEquity, last quarter 3.17b)
Debt / EBITDA = -0.12 (Net Debt -88.8m / EBITDA 727.3m)
Debt / FCF = -0.19 (Net Debt -88.8m / FCF TTM 462.3m)
Total Stockholder Equity = 2.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.79% (Net Income 490.4m / Total Assets 30.0b)
RoE = 16.41% (Net Income TTM 490.4m / Total Stockholder Equity 2.99b)
RoCE = 16.30% (EBIT 646.7m / Capital Employed (Equity 2.99b + L.T.Debt 979.6m))
RoIC = 9.96% (NOPAT 490.4m / Invested Capital 4.92b)
WACC = 7.44% (E(5.11b)/V(6.18b) * Re(9.0%) + (debt cost/tax rate unavailable))
Discount Rate = 9.0% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -41.29 | Cagr: -0.23%
[DCF] Terminal Value 76.20% ; FCFF base≈451.8m ; Y1≈476.2m ; Y5≈555.9m
[DCF] Fair Price = 152.1 (EV 8.56b - Net Debt -88.8m = Equity 8.65b / Shares 56.9m; r=8.35% [WACC [floored]]; 5y FCF grow 5.99% → 2.50% )
EPS Correlation: 95.45 | EPS CAGR: 15.08% | SUE: 2.75 | # QB: 1
Revenue Correlation: 92.91 | Revenue CAGR: 14.16% | SUE: 3.28 | # QB: 3
EPS current Quarter (2026-09-30): EPS=2.26 | Chg30d=+0.00% | Revisions=+17% | Analysts=7
EPS next Quarter (2026-12-31): EPS=2.39 | Chg30d=-0.06% | Revisions=-17% | Analysts=7
EPS current Year (2027-06-30): EPS=9.68 | Chg30d=+0.19% | Revisions=+25% | GrowthEPS=+10.7% | GrowthRev=+9.6%
EPS next Year (2028-06-30): EPS=10.79 | Chg30d=-0.09% | Revisions=+0% | GrowthEPS=+11.5% | GrowthRev=+10.6%
[Analyst] Revisions Ratio: +10% (up=4, down=3)